Back to results
US 12,576,127 B2Granted
Fibroblast binding agents and use thereof
AssigneesOrionis Biosciences BV, Vib Vzw, Universiteit Gent
InventorsNikolai Kley, Jan Tavernier, Anje Cauwels
Life of this patent
Estimating the term…
Abstract
The present invention relates, in part, to agents that bind fibroblast activation protein (FAP) and their use as diagnostic and therapeutic agents. The present invention further relates to pharmaceutical compositions comprising the FAP binding agents and their use in the treatment of various diseases.
Claims8
A fibroblast activation protein (FAP) binding agent comprising a recombinant heavy-chain-only antibody (VHH) comprising three complementarity determining regions (CDR1, CDR2, and CDR3), wherein:
- (a) CDR1 comprises an amino acid sequence of SEQ ID NO:
- 95 or any one of SEQ ID NOS:
- 87 to 94 or SEQ ID NOS:
- 96 to 115;
- (b) CDR2 comprises an amino acid sequence of SEQ ID NO:
- 121 or any one of SEQ ID NOS:
- 116 to 120 or SEQ ID NOS:
- 122 to 144;
- and
- (c) CDR3 comprises an amino acid sequence of SEQ ID NO:
- 152 or any one of SEQ ID NOS:
- 145 to 151 or SEQ ID NOS:
- 153 to 175.
10 more elements
Dependencies are inferred from the claim text.